130 related articles for article (PubMed ID: 8596492)
1. Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus.
Orskov L; Møller N; Bak JF; Pørksen N; Schmitz O
Metabolism; 1996 Feb; 45(2):211-7. PubMed ID: 8596492
[TBL] [Abstract][Full Text] [Related]
2. Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients.
Bruttomesso D; Fongher C; Silvestri B; Barberio S; Marescotti MC; Iori E; Valerio A; Crazzolara D; Pianta A; Tiengo A; Del Prato S
Diabetes Res Clin Pract; 2001 Feb; 51(2):97-105. PubMed ID: 11165689
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.
Crowne EC; Samra JS; Cheetham T; Watts A; Holly JM; Dunger DB
Metabolism; 1998 Jan; 47(1):31-8. PubMed ID: 9440474
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of muscle glucose disposal by insulin in humans is a function of the preexisting plasma insulin level.
Vogt C; Petrides AS
Am J Physiol; 1995 May; 268(5 Pt 1):E1031-8. PubMed ID: 7762630
[TBL] [Abstract][Full Text] [Related]
5. Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion.
Tuominen JA; Ebeling P; Vuorinen-Markkola H; Koivisto VA
Diabet Med; 1997 Apr; 14(4):301-8. PubMed ID: 9113484
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
[TBL] [Abstract][Full Text] [Related]
7. Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients.
Lunetta M; Di Mauro M; Le Moli R; Nicoletti F
Diabetes Res Clin Pract; 1997 Nov; 38(2):81-9. PubMed ID: 9483371
[TBL] [Abstract][Full Text] [Related]
8. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
[TBL] [Abstract][Full Text] [Related]
10. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
11. Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects.
Schmitz O; Pedersen SB; Mengel A; Pørksen N; Bak J; Møller N; Richelsen B; Alberti KG; Butler PC; Orskov H
Metabolism; 1994 Jul; 43(7):842-6. PubMed ID: 7913205
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects.
Orskov L; Schmitz O; Bak JF; Lund S; Kaal A; Nyholm B; Møller N
Scand J Clin Lab Invest; 2001; 61(5):371-81. PubMed ID: 11569484
[TBL] [Abstract][Full Text] [Related]
13. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus.
Kirkegaard C; Nørgaard K; Snorgaard O; Bek T; Larsen M; Lund-Andersen H
Acta Endocrinol (Copenh); 1990 Jun; 122(6):766-72. PubMed ID: 2197845
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
15. Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with IDDM.
Cohen N; Halberstam M; Rossetti L; Shamoon H
Am J Physiol; 1996 Aug; 271(2 Pt 1):E284-93. PubMed ID: 8770022
[TBL] [Abstract][Full Text] [Related]
16. The effect of the somatostatin analogue octreotide on growth hormone secretion in insulin-dependent diabetics without residual insulin secretion.
Wurzburger MI; Prelevic GM; Sonksen PH; Balint-Peric LA
Horm Metab Res; 1992 Jul; 24(7):329-32. PubMed ID: 1516889
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the insulin-antagonistic effect of growth hormone in insulin-dependent diabetes mellitus.
Fowelin J; Attvall S; von Schenck H; Smith U; Lager I
Diabet Med; 1995 Nov; 12(11):990-6. PubMed ID: 8582132
[TBL] [Abstract][Full Text] [Related]
18. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin).
Mimura A; Kageyama S; Maruyama M; Ikeda Y; Isogai Y
Horm Metab Res; 1994 Apr; 26(4):184-7. PubMed ID: 8082872
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes.
Svart MV; Rittig N; Kampmann U; Voss TS; Møller N; Jessen N
Diabetologia; 2017 Jul; 60(7):1197-1206. PubMed ID: 28389705
[TBL] [Abstract][Full Text] [Related]
20. Androgens and insulin resistance in type 1 diabetic men.
Ebeling P; Stenman UH; Seppälä M; Koivisto VA
Clin Endocrinol (Oxf); 1995 Nov; 43(5):601-7. PubMed ID: 8548945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
